| pubmed-article:11061615 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11061615 | lifeskim:mentions | umls-concept:C0302592 | lld:lifeskim |
| pubmed-article:11061615 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:11061615 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:11061615 | lifeskim:mentions | umls-concept:C0005740 | lld:lifeskim |
| pubmed-article:11061615 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:11061615 | lifeskim:mentions | umls-concept:C0020823 | lld:lifeskim |
| pubmed-article:11061615 | lifeskim:mentions | umls-concept:C1415761 | lld:lifeskim |
| pubmed-article:11061615 | lifeskim:mentions | umls-concept:C0282461 | lld:lifeskim |
| pubmed-article:11061615 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
| pubmed-article:11061615 | lifeskim:mentions | umls-concept:C0332283 | lld:lifeskim |
| pubmed-article:11061615 | lifeskim:mentions | umls-concept:C0205187 | lld:lifeskim |
| pubmed-article:11061615 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:11061615 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:11061615 | pubmed:dateCreated | 2001-1-31 | lld:pubmed |
| pubmed-article:11061615 | pubmed:abstractText | Phase II studies have shown primary (neo-adjuvant) chemotherapy with bleomycin, ifosfamide and cisplatin (BIP) is active against inoperable cervical cancer. We present here results of a randomised phase III multicentre trial comparing radical radiotherapy with neo-adjuvant BIP chemotherapy followed by radical radiotherapy in patients with inoperable cervical cancer, designed to discover whether this combination might improve survival. | lld:pubmed |
| pubmed-article:11061615 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11061615 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11061615 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11061615 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11061615 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11061615 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11061615 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11061615 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:11061615 | pubmed:issn | 0923-7534 | lld:pubmed |
| pubmed-article:11061615 | pubmed:author | pubmed-author:DunnJJ | lld:pubmed |
| pubmed-article:11061615 | pubmed:author | pubmed-author:BurtonAA | lld:pubmed |
| pubmed-article:11061615 | pubmed:author | pubmed-author:TobiasJJ | lld:pubmed |
| pubmed-article:11061615 | pubmed:author | pubmed-author:PooleC JCJ | lld:pubmed |
| pubmed-article:11061615 | pubmed:author | pubmed-author:JordanSS | lld:pubmed |
| pubmed-article:11061615 | pubmed:author | pubmed-author:BuxtonJJ | lld:pubmed |
| pubmed-article:11061615 | pubmed:author | pubmed-author:LuesleyDD | lld:pubmed |
| pubmed-article:11061615 | pubmed:author | pubmed-author:HerodJJ | lld:pubmed |
| pubmed-article:11061615 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11061615 | pubmed:volume | 11 | lld:pubmed |
| pubmed-article:11061615 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11061615 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11061615 | pubmed:pagination | 1175-81 | lld:pubmed |
| pubmed-article:11061615 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11061615 | pubmed:meshHeading | pubmed-meshheading:11061615... | lld:pubmed |
| pubmed-article:11061615 | pubmed:meshHeading | pubmed-meshheading:11061615... | lld:pubmed |
| pubmed-article:11061615 | pubmed:meshHeading | pubmed-meshheading:11061615... | lld:pubmed |
| pubmed-article:11061615 | pubmed:meshHeading | pubmed-meshheading:11061615... | lld:pubmed |
| pubmed-article:11061615 | pubmed:meshHeading | pubmed-meshheading:11061615... | lld:pubmed |
| pubmed-article:11061615 | pubmed:meshHeading | pubmed-meshheading:11061615... | lld:pubmed |
| pubmed-article:11061615 | pubmed:meshHeading | pubmed-meshheading:11061615... | lld:pubmed |
| pubmed-article:11061615 | pubmed:meshHeading | pubmed-meshheading:11061615... | lld:pubmed |
| pubmed-article:11061615 | pubmed:meshHeading | pubmed-meshheading:11061615... | lld:pubmed |
| pubmed-article:11061615 | pubmed:meshHeading | pubmed-meshheading:11061615... | lld:pubmed |
| pubmed-article:11061615 | pubmed:meshHeading | pubmed-meshheading:11061615... | lld:pubmed |
| pubmed-article:11061615 | pubmed:meshHeading | pubmed-meshheading:11061615... | lld:pubmed |
| pubmed-article:11061615 | pubmed:meshHeading | pubmed-meshheading:11061615... | lld:pubmed |
| pubmed-article:11061615 | pubmed:meshHeading | pubmed-meshheading:11061615... | lld:pubmed |
| pubmed-article:11061615 | pubmed:meshHeading | pubmed-meshheading:11061615... | lld:pubmed |
| pubmed-article:11061615 | pubmed:meshHeading | pubmed-meshheading:11061615... | lld:pubmed |
| pubmed-article:11061615 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:11061615 | pubmed:articleTitle | A randomised, prospective, phase III clinical trial of primary bleomycin, ifosfamide and cisplatin (BIP) chemotherapy followed by radiotherapy versus radiotherapy alone in inoperable cancer of the cervix. | lld:pubmed |
| pubmed-article:11061615 | pubmed:affiliation | CRC Trials Unit, Institute for Cancer Studies, University of Birmingham, Edgbaston, UK. | lld:pubmed |
| pubmed-article:11061615 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11061615 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11061615 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:11061615 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:11061615 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:11061615 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:11061615 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
